Statement Of Financial Position [Abstract]

BerGenBio - Filing #5877180

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Cash and cash equivalents
140,155,000 NOK
156,421,000 NOK
150,803,000 NOK
Assets
155,796,000 NOK
174,335,000 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
39,087,000 NOK
268,869,000 NOK
Retained earnings
22,019,000 NOK
189,234,000 NOK
Share premium
8,899,000 NOK
854,000 NOK
Equity
22,019,000 NOK
8,899,000 NOK
52,696,000 NOK
122,702,000 NOK
39,087,000 NOK
854,000 NOK
268,869,000 NOK
189,234,000 NOK
46,987,000 NOK
127,476,000 NOK
88,498,000 NOK
8,866,000 NOK
35,780,000 NOK
0 NOK
43,852,000 NOK
Liabilities [abstract]
Liabilities
33,095,000 NOK
46,859,000 NOK
Equity and liabilities
155,796,000 NOK
174,335,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.